AS-1763

· Carna Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AS-1763, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma [Phase 1]